Karolinska Development operates in the investment industry and focuses on long-term equity investments in biotechnology and pharmaceutical companies. The company's portfolio includes companies in sectors such as biotechnology and medical technology. The operations are primarily concentrated in Sweden, with a main presence in the Stockholm region. Karolinska Development was founded in 2003 and is headquartered in Stockholm, Sweden.